Biotechnology
Manufacturing
Health

Biogen

$217.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.79 (0.36%) Today
+$0.79 (0.36%) Today

Why Robinhood?

You can buy or sell Biogen and other stocks, options, ETFs, and crypto commission-free!

About

Biogen Inc. Common Stock, also called Biogen, is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Read More It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Employees
7,800
Headquarters
Cambridge, Massachusetts
Founded
1978
Market Cap
42.74B
Price-Earnings Ratio
10.07
Dividend Yield
0.00
Average Volume
1.60M
High Today
$221.27
Low Today
$217.19
Open Price
$220.21
Volume
709.44K
52 Week High
$388.67
52 Week Low
$216.49

Collections

Biotechnology
Manufacturing
Health
Therapy
Technology
US
North America

News

Yahoo Finance35m

Biogen announces $5 billion buyback days after shelving Alzheimer's trials

(Reuters) - Biogen Inc said on Monday it would buy back shares worth $5 billion, days after its stock slumped on the drugmaker's announcement to end two Alzheimer's disease trials.

81
Seeking Alpha56m

Biogen OKs $5B share buyback plan

The board of Biogen (NASDAQ:BIIB) has authorized a $5B Share Repurchase Program, in addition to the ~$1.7B remaining under the program announced in August 2018. Shares are up 2% premarket....

53
Seeking Alpha1h

Biogen boosts buyback; shares up 1.5%

In the wake of last week's aducanumab-related plunge, Biogen (NASDAQ:BIIB) this morning announces a $5B addition to its buyback program.

63

Earnings

$4.52
$5.48
$6.44
$7.40
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Available Apr 24, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.